S&P 500

5.440,69

0,17%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Creative Medical Technology Holdings Inc (CELZ)
Creative Medical Technology Holdings Inc (CELZ) Notícias

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CELZ

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/06/2024	17:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
17/05/2024	17:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
17/05/2024	17:01	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
10/05/2024	17:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
27/03/2024	10:00	Business Wire	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
07/03/2024	11:15	Business Wire	Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
06/03/2024	18:10	AllPennyStocks.com	Biotech Finds Mid-Week Success Following FDA Announcement	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
06/03/2024	09:00	Business Wire	Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
10/10/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
19/09/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
29/06/2023	18:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
29/06/2023	18:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
28/06/2023	10:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
28/06/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
12/06/2023	09:01	PR Newswire (US)	Creative Medical Technology Announces $2 Million Share Repurchase Program	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
09/06/2023	13:30	PR Newswire (US)	Creative Medical Technology Holdings Announces Reverse Stock Split	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
31/05/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
22/05/2023	09:30	PR Newswire (US)	Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
18/05/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
12/05/2023	17:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
01/05/2023	17:47	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
12/04/2023	16:30	AllPennyStocks.com	Biotech Up Massively On Follow-Up Data	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
12/04/2023	09:00	PR Newswire (US)	Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
04/04/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
31/03/2023	17:47	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
23/03/2023	09:00	PR Newswire (US)	Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
21/03/2023	09:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
07/03/2023	10:00	Business Wire	Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
14/02/2023	10:00	Business Wire	Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
08/02/2023	10:00	PR Newswire (US)	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes	NASDAQ:CELZ	Creative Medical Technology Holdings Inc